Report from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry--North America. Clin Transpl 1994:87-98
Date
01/01/1994Pubmed ID
7547596Scopus ID
2-s2.0-0028700481 (requires institutional sign-in at Scopus site) 4 CitationsAbstract
Bone marrow transplants are an effective treatment for many life-threatening diseases. Considerations for use include potential for cure, availability of a suitable donor, feasibility of using autologous stem cells, and risks of transplant-related mortality. Not addressed in this article, but also important, is consideration of the relative efficacy of conventional therapy in specific settings. The IBMTR and ABMTR offer a unique resource for examining the role of allogeneic and autologous transplants in cancer treatment.
Author List
Rowlings PA, Passweg JR, Armitage JO, Gale RP, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MMAuthors
Mary M. Horowitz MD, MS Professor in the Medicine department at Medical College of WisconsinMei-Jie Zhang PhD Professor in the Institute for Health and Equity department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
Actuarial AnalysisBlood Transfusion, Autologous
Bone Marrow Transplantation
Global Health
Hematopoietic Stem Cell Transplantation
Humans
International Agencies
Leukemia
Lymphoma
Neoplasms
Registries
Retrospective Studies
Survival Analysis